日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "Biomimetic dynamic nanomedicine SrHCF: Lattice self-reconstruction based on Fe(2+) response to achieve synergistic "ferrous chelation-antioxidation-calcium antagonism-inflammation inhibition" quadruple treatment of CIRI" [Bioact. Mater. 55 (2026) 23-41]

对“仿生动态纳米药物 SrHCF:基于 Fe(2+) 响应的晶格自重构实现对 CIRI 的协同‘亚铁螯合-抗氧化-钙拮抗-炎症抑制’四重治疗”的更正 [Bioact. Mater. 55 (2026) 23-41]

Xiong, Tingli; Wang, Shuya; Shi, Xiaojing; Li, Ruishi; Zheng, Wenxuan; Qi, Weimin; Liu, Min; Dai, Lin; Huang, Qiong; Ai, Kelong

Biomimetic dynamic nanomedicine SrHCF: Lattice self-reconstruction based on Fe(2+) response to achieve synergistic "ferrous chelation-antioxidation-calcium antagonism-inflammation inhibition" quadruple treatment of CIRI

仿生动态纳米药物SrHCF:基于Fe(2+)响应的晶格自重构,实现CIRI的“亚铁螯合-抗氧化-钙拮抗-炎症抑制”四重协同治疗

Xiong, Tingli; Wang, Shuya; Shi, Xiaojing; Li, Ruishi; Zheng, Wenxuan; Qi, Weimin; Liu, Min; Dai, Lin; Huang, Qiong; Ai, Kelong

Heart-homed nanomedicine induces fast mitochondrial rescue to enhance cardiac function post-myocardial infarction

靶向心脏的纳米药物可快速修复线粒体,从而增强心肌梗死后的心脏功能

Qi, Weimin; Wang, Jue; Wang, Shuya; Shi, Xiaojing; Xiong, Tingli; Li, Ruishi; Zheng, Wenxuan; Liu, Min; Deng, Shusheng; Huang, Qiong; Liu, Jianhua; Ai, Kelong

Angiogenesis in rheumatoid Arthritis: Pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies

类风湿性关节炎中的血管生成:病理特征、致病机制和纳米靶向治疗策略

Zhao, Fang; Hu, Zeyu; Li, Gejing; Liu, Min; Huang, Qiong; Ai, Kelong; Cai, Xiong

Polydopamine as a biocompatible and precise mitochondrial targeted therapeutic platform for reversing myocardial ischemia-reperfusion injury.

聚多巴胺作为一种生物相容性好、精准靶向线粒体的治疗平台,可用于逆转心肌缺血再灌注损伤。

Zhao Tianjiao, Huang Yunying, Chen Wensheng, Qi Weimin, Wang Jue, Xia Yingci, Zhou Jia, Long Xingyu, Nan Yayun, Huang Qiong, Ai Kelong

Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease.

适应性抗氧化纳米药物抑制肾小管上皮细胞铁死亡,从而缓解糖尿病肾病。

Liu Zerun, Huang Ting, Hong Ying, Yang Yuqi, Chen Wensheng, Zeng Qingtao, Chen Qiaohui, Yang Yongqi, Ying Xiaohong, Zeng Wan, Wu Ziyu, Zhao Tianjiao, Wan Xuesi, Chen Jianlin, Ai Kelong, Huang Qiong

Nanomedicine Penetrating Blood-Pancreas Barrier for Effective Treatment of Acute Pancreatitis.

纳米药物穿透血胰屏障,有效治疗急性胰腺炎

Wang Dan, Wang Shuya, Liu Jinjin, Shi Xiaojing, Xiong Tingli, Li Ruishi, Wei Wei, Ji Liandong, Huang Qiong, Gong Xuejun, Ai Kelong

Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy

通过纳米颗粒介导的STING激动剂协同作用增强放射疗法诱导的抗肿瘤免疫

Zeng, Qian; Liu, Min; Wang, Ziqi; Zhou, Rongrong; Ai, Kelong

UCP2 inhibition eliminates pancreatic β cell autoinflammation in T2DM with islet-mitochondrial sequential targeting nanomedicines

利用胰岛-线粒体顺序靶向纳米药物抑制UCP2可消除2型糖尿病中的胰腺β细胞自身炎症

Liu, Zerun; Chen, Wensheng; Zhang, Jinping; Huang, Ting; Hong, Ying; Zhao, Tianjiao; Liu, Min; Chen, Qiaohui; Yang, Yongqi; Wang, Shuya; Wang, Jue; Ying, Xiaohong; Li, Yiming; Huang, Qiong; Ai, Kelong

An eNOS-like nanomaterial for specific reversal of cerebral ischemia-reperfusion injury

一种类似eNOS的纳米材料,可特异性逆转脑缺血再灌注损伤。

Wang, Shuya; Xiang, Yuting; Shi, Xiaojing; Xiong, Tingli; Li, Ruishi; Zheng, Wenxuan; Chen, Wensheng; Chen, Qiaohui; Yang, Yongqi; Wang, Jue; Huang, Qiong; Ai, Kelong